Swinford, Cecily G.
Risacher, Shannon L.
Wu, Yu-Chien
Apostolova, Liana G.
Gao, Sujuan
Bice, Paula J.
Saykin, Andrew J. http://orcid.org/0000-0002-1376-8532
Funding for this research was provided by:
National Institute on Aging (K01 AG049050, R01 AG061788, R01 AG053993, P30 AG010133, P30 AG072976, R01 AG019771, R01 AG057739, U01 AG024904, R01 AG068193, T32 AG071444, U01 AG068057, U01 AG072177)
U.S. National Library of Medicine (R01 LM013463)
Charleston Conferences (New Vision Award)
Article History
Received: 23 March 2022
Revised: 26 September 2022
Accepted: 20 November 2022
First Online: 9 December 2022
Declarations
:
: Dr. Apostolova receives support in the form of consulting fees from Biogen, Two Labs, IQVIA, NIH, Florida Department of Health, NIH Biobank, Eli Lilly, GE Healthcare, and Eisai; in the form of payment for lectures, etc. from AAN, MillerMed, AiSM, and Health and Hospitality; and in the form of travel and meeting support from Alzheimer’s Association. She also participates on Data Safety Monitoring or Advisory boards for IQVIA, NIA R01 AG061111, UAB Nathan Shock Center, and New Mexico Exploratory ADRC; in leadership roles for Medical Science Council Alzheimer Association Greater IN Chapter, Alzheimer Association Science Program Committee, and FDA PCNS Advisory Committee; stock or stock options Cassava Neurosciences and Golden Seeds, and receipt of materials, etc. from AVID Pharmaceuticals, Life Molecular Imaging, and Roche Diagnostics. Dr. Saykin serves or served on the following: Bayer Oncology (Scientific Advisory Board), Eisai (Scientific Advisory Board), Siemens Medical Solutions USA, Inc. (Dementia Advisory Board), and Springer-Nature Publishing (Editorial Office Support as Editor-in-Chief, Brain Imaging and Behavior). All other authors report no disclosures.